Literature DB >> 27831997

Pulmonary Arterial Compliance Improves Rapidly After Left Ventricular Assist Device Implantation.

S Carolina Masri1, Ryan J Tedford, Monica M Colvin, Peter J Leary, Rebecca Cogswell.   

Abstract

Pulmonary artery compliance (PAC) contributes to right ventricular (RV) afterload, is decreased in the setting of increased left ventricular (LV) filling pressures, and may be an important component of World Health Organization (WHO) group II pulmonary hypertension (PH). Left ventricular assist device (LVAD) implantation can rapidly change LV filling, but its relationship with PAC is unknown. Right heart catheterization was performed preoperatively, postoperatively (between 48 and 72 hours), and >30 days post-LVAD implantation in a cohort of 64 patients with end-stage systolic heart failure. Within 72 hours, LVAD implantation was associated with an increase in PAC (2.0-3.7 ml/mm Hg, p < 0.0001), a decrease in pulmonary vascular resistance (3.5-1.7 Wood units, p < 0.0001). Pulmonary arterial compliance did not increase further at the >30 post-LVAD time point (3.7 ± 1.7 to 3.6 ± 0.44 ml/mm Hg, p = 0.44). Pulmonary artery compliance improves rapidly after LVAD implantation. This suggests that more permanent changes in the pulmonary vascular bed may not be responsible for the abnormal PAC observed in WHO group II PH.

Entities:  

Mesh:

Year:  2017        PMID: 27831997     DOI: 10.1097/MAT.0000000000000467

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  11 in total

Review 1.  Pulmonary Hypertension Due to Left Heart Disease: an Update.

Authors:  Mandar A Aras; Mitchell A Psotka; Teresa De Marco
Journal:  Curr Cardiol Rep       Date:  2019-05-27       Impact factor: 2.931

2.  Endothelin-1, cardiac morphology, and heart failure: the MESA angiogenesis study.

Authors:  Peter J Leary; Nancy S Jenny; David A Bluemke; Steven M Kawut; Richard A Kronmal; Joao A Lima; Bradley A Maron; David D Ralph; Samuel G Rayner; John J Ryan; Zachary L Steinberg; Karen D Hinckley Stukovsky; Ryan J Tedford
Journal:  J Heart Lung Transplant       Date:  2019-08-10       Impact factor: 10.247

Review 3.  Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.

Authors:  Bhavadharini Ramu; Brian A Houston; Ryan J Tedford
Journal:  Curr Heart Fail Rep       Date:  2018-04

4.  Understanding Longitudinal Changes in Pulmonary Vascular Resistance After Left Ventricular Assist Device Implantation.

Authors:  Gaurav Gulati; Robin Ruthazer; David Denofrio; Amanda R Vest; David Kent; Michael S Kiernan
Journal:  J Card Fail       Date:  2021-01-12       Impact factor: 5.712

5.  Outcomes With Phosphodiesterase-5 Inhibitor Use After Left Ventricular Assist Device: An STS-INTERMACS Analysis.

Authors:  E Wilson Grandin; Gaurav Gulati; Jose I Nunez; Kevin Kennedy; J Eduardo Rame; Pavan Atluri; Francis D Pagani; James K Kirklin; Robert L Kormos; Jeffrey Teuteberg; Michael S Kiernan
Journal:  Circ Heart Fail       Date:  2022-03-25       Impact factor: 10.447

6.  Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.

Authors:  Stefano Ghio; Gabriele Crimi; Silvia Pica; Pier Luigi Temporelli; Massimo Boffini; Mauro Rinaldi; Claudia Raineri; Laura Scelsi; Massimo Pistono; Rossana Totaro; Stefania Guida; Luigi Oltrona Visconti
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

7.  Pulmonary hypertension due to left heart disease.

Authors:  Jean-Luc Vachiéry; Ryan J Tedford; Stephan Rosenkranz; Massimiliano Palazzini; Irene Lang; Marco Guazzi; Gerry Coghlan; Irina Chazova; Teresa De Marco
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

8.  Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Emmanouil Tampakakis; Sanjiv J Shah; Barry A Borlaug; Peter J Leary; Harnish H Patel; Wayne L Miller; Benjamin W Kelemen; Brian A Houston; Todd M Kolb; Rachel Damico; Stephen C Mathai; Edward K Kasper; Paul M Hassoun; David A Kass; Ryan J Tedford
Journal:  Circ Heart Fail       Date:  2018-04       Impact factor: 8.790

Review 9.  Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues.

Authors:  Emmanuelle Berthelot; Fabrice Bauer; Jean-Christophe Eicher; Erwan Flécher; Barnabas Gellen; Julien Guihaire; Damien Guijarro; Gérald Roul; Muriel Salvat; Christophe Tribouilloy; Florian Zores; Nicolas Lamblin; Pascal de Groote; Thibaud Damy
Journal:  ESC Heart Fail       Date:  2018-07-20

10.  Changes in pulmonary artery pressure before and after left ventricular assist device implantation in patients utilizing remote haemodynamic monitoring.

Authors:  Ahmet Kilic; Jason N Katz; Susan M Joseph; Meredith A Brisco-Bacik; Nir Uriel; Brian Lima; Rahul Agarwal; Rupinder Bharmi; David J Farrar; Sangjin Lee
Journal:  ESC Heart Fail       Date:  2018-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.